
How one American inventor unknowingly unleashed two of the planet's greatest environmental disasters
Thomas Midgley Jr., once hailed as a genius, invented two revolutionary solutions—leaded gasoline and CFCs—that unknowingly became environmental disasters.
In the annals of invention, few names echo with such tragic irony as that of Thomas Midgley Jr. Hailed in his lifetime as a chemical wizard who solved the mechanical ailments of a rapidly modernizing world, Midgley's innovations were initially celebrated as miraculous breakthroughs. Yet in the cold clarity of hindsight, his inventions are seen as environmental catastrophes of epic scale — twin disasters that humanity is still struggling to undo. One soot-blackened, gasping century after he stood before journalists in 1924, grinning as he poured a lethal chemical over his hands and inhaled its toxic fumes to prove a point, the damage is still unfolding.
Midgley didn't just change the world — he unintentionally poisoned it. It was a time of boundless belief in science. The United States was roaring through the 1920s, driven by the promise of machines, speed, and petroleum. In this high-octane climate, Midgley — a chemical engineer working for General Motors — was tasked with fixing a problem that threatened the future of automobiles: engine knock. After testing thousands of substances, Midgley struck upon tetraethyl lead, a compound that silenced the problem and gave birth to 'Ethyl' gasoline. At a press event, he theatrically doused his hands in the compound and inhaled its fumes to allay public fears. But soon after, he himself would fall ill. The irony? He was already poisoned, and so was the world.
Despite the already known dangers of lead, which can severely impair cognitive development — particularly in children — the product was a commercial success. It powered cars and economies. It also contaminated soil, poisoned air, and irreparably harmed generations. The World Health Organization still estimates that a million people die each year from lead poisoning, long after the compound's use was banned in most countries.
Having seemingly solved one global dilemma, Midgley turned to another: how to replace the toxic and flammable gases then used in refrigeration and air conditioning. Again, he succeeded — and again, the consequences would prove catastrophic. In 1930, Midgley introduced Freon, the first chlorofluorocarbon (CFC). Marketed as safe and efficient, Freon transformed daily life. Air conditioning became accessible. Spray cans became ubiquitous. But the molecule's stability — once its greatest virtue — was its deadliest flaw. CFCs rose into the stratosphere, where they began to eat away at the ozone layer, Earth's natural sunscreen.
It wasn't until the 1970s, decades after Midgley's death, that scientists realized what had happened. A hole in the ozone layer had opened above Antarctica, threatening all life with heightened UV exposure. The global response was swift — by 1987, the Montreal Protocol aimed to phase out CFCs. Even so, scientists estimate it will take another 40 to 50 years before the ozone layer fully recovers.
Leaded gasoline, despite its known risks, was not fully phased out globally until 2021. Its final holdout, Algeria, continued sales into the 21st century. And even now, aviation fuels still contain lead additives. A 2022 study found that half of all Americans alive today may have been exposed to dangerous levels of lead as children — a staggering public health legacy tied back to Midgley's 'miracle fuel.' In both cases — Ethyl and Freon — Midgley was hailed as a savior, awarded medals, lauded in scientific journals, and immortalized by institutions. But his tale did not have a heroic end. Stricken by polio in 1940, Midgley became severely disabled. Ever the inventor, he designed a contraption of pulleys and ropes to help him move independently between his bed and a wheelchair. But on November 2, 1944, he became fatally entangled in his own device. Officially ruled a suicide by some, his death has long been shrouded in tragic symbolism — a man strangled by his own creation.
According to a report from CNN , some historians including Radford University's Bill Kovarik, Midgley may have been haunted by guilt in his final years. 'He had a tremendous sense of guilt,' said Kovarik. 'The lead poisoning could have contributed to his psychosis.' Today, it's tempting to paint Midgley as the villain — the man who, more than anyone else, broke the sky and poisoned the air. But historians warn against such simplification. He was, they argue, a cog in the great industrial machinery of the 20th century — a man responding to the demands of corporate giants like GM and DuPont, within a society intoxicated by progress.
'Had it not been Midgley, I'm sure it would have been somebody else,' said historian Gerald Markowitz according to CNN . 'He was just an employee.' Indeed, his story is not just about one man's fatal brilliance. It is a cautionary tale about the blind pursuit of innovation, the arrogance of unchecked industry, and the long shadow of scientific oversight. It is about how the very notion of 'progress' was once considered an unquestioned good — even when it poisoned the Earth in the process. Today, as we stand beneath a slowly healing ozone layer and breathe in a world still contaminated by lead, Midgley's story remains both a haunting warning and a call to humility. Science can illuminate, but it can also blind. Invention can uplift, but it can also entangle. Midgley didn't live to see the damage unfold. But his tale is far from over. It lingers in the air we breathe, in the soil beneath our cities, and in the sky above our heads — a legacy both invisible and inescapable. And perhaps, just perhaps, in remembering him, we can remember the cost of forgetting caution.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
an hour ago
- Time of India
5 lifestyle-based remedies to reverse diabetes naturally
As deadly as diabetes is, it continues to rise at an alarming rate in India, and the spotlight is shifting towards all-natural and sustainable approaches to manage this fatal condition. Now that people are growing interested in lifestyle-based interventions, experts are highlighting the role of everyday habits and simple home remedies that are beneficial in potentially reversing type 2 diabetes. Did you know? According to multiple health reports, approximately 77 million adults in India are currently living with diabetes. In addition to that, around 25 million people fall under the category of prediabetic. A 2023 estimate put the country's number of diabetes cases at 101 million. Shockingly, the World Health Organization (WHO) estimates that more than half of them are not even aware of having the disease. Social media is significantly helping people find alternatives to heavy medication dosages. One such initiative that is gaining traction on social media is a health awareness series titled #MagicBoard, where certified dietitian Sonia Narang tells the world about five practical strategies for controlling and toning down blood sugar levels. Combining magical and traditional Indian home remedies with nutritional science, her advice is designed for those seeking effective and medicine-free solutions. Ms. Sonia's method focuses on five pillars: fenugreek seed water, onion salad, cold-pressed oils, post-meal walking, and amla-haldi water. Each of which is easy to follow and backed by known metabolic benefits. Let us get into it Fenugreek seed water This is a natural morning regulator. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Over 40 and Struggling With Belly Fat? Try 1 Teaspoon Daily (See Results Fast!) getfittoday Undo Start your day with a glass of this soaked fenugreek seed water. Take a tablespoon of seeds and soak them overnight in water. In the morning, individuals may notice sudden improvements in blood sugar control. Fenugreek contains soluble fiber and compounds that enhance insulin sensitivity and reduce glucose absorption in the intestine. Onion salad Onion salad is a source of power of raw nutrition. Raw onion, which is commonly neglected in contemporary diets, proves to be very important in controlling blood sugar. A mere 100 grams of raw onion is sufficient to lower blood glucose levels within four hours. The sulfur compounds and flavonoids, such as quercetin, enhance the body's insulin response, along with promoting cardiovascular health. Cold-pressed oils Refined oils are also known to make insulin resistance even worse because of their trans fats and high levels of omega-6 fatty acids. Cold-pressed oils, on the other hand, maintain the natural balance of their fatty acids and anti-inflammatory effects. They also reduce LDL (bad) cholesterol and promote heart and metabolic health. Walking 500 steps after meals A 500-step walk after every meal can have a dramatic effect on glucose metabolism. Walking after meals allows muscles to utilize glucose, and it decreases blood sugar spikes. This also reduces the risk of insulin resistance, promotes digestion, and helps manage weight—all critical aspects for diabetes management. Amla-haldi water at night The last tip includes a nightcap of amla (Indian gooseberry) and haldi (turmeric). Amla is a chromium-rich natural source that enhances insulin sensitivity, and turmeric has curcumin, which is anti-inflammatory and lowers glucose. They work together to aid detoxification, balance cholesterol, and enhance glucose metabolism at night. Remember that anything until tried is not tested. As public awareness about diabetes increases, such lifestyle-based strategies may soon become a cornerstone of diabetes management in India. One step to a healthier you—join Times Health+ Yoga and feel the change


India.com
2 hours ago
- India.com
COVID 19 Cases in India: Active Cases Jump To 6491
COVID 19 Cases Rising In India Live Updates: India is once again witnessing an unsettling rise in COVID-19 cases, with the number of active infections climbing to 6491; according to the Ministry of Health and Family Welfare's latest update as of 12:00 AM IST, June 9, 2025. As per May 2025 classifications by the World Health Organization (WHO), subvariants LF.7 and NB.1.8.1 are categorized as Variants Under Monitoring, meaning they are not yet deemed as Variants of Concern or Variants of Interest. However, these strains are suspected to be contributing to the rising infections not just in India but also across China and other parts of Asia. Despite the emergence of new subvariants, the JN.1 strain remains the most dominant, accounting for a staggering 53% of all positive cases across the country. According to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), a case of NB.1.8.1 was detected in Tamil Nadu in April, while four cases of LF.7 were identified in Gujarat earlier this month. With the virus subtly shifting form and symptoms evolving, health authorities are urging the public to maintain precautionary measures, including hygiene, mask use in crowded places, and timely testing. Although hospitalisation remains low, experts warn that complacency could reverse progress. Stay informed, and if you're experiencing mild symptoms like fatigue, a sore throat, or gastrointestinal discomfort, it's best to test early and isolate to prevent further spread.


NDTV
3 hours ago
- NDTV
Measles Cases Are Surging Globally. Should Children Be Vaccinated Earlier?
Measles has been rising globally in recent years. There were an estimated 10.3 million cases worldwide in 2023, a 20% increase from 2022. Outbreaks are being reported all over the world including in the United States, Europe and the Western Pacific region (which includes Australia). For example, Vietnam has reportedly seen thousands of cases in 2024 and 2025. In Australia, 77 cases of measles have been recorded in the first five months of 2025, compared with 57 cases in all of 2024. Measles cases in Australia are almost all related to international travel. They occur in travellers returning from overseas, or are contracted locally after mixing with an infected traveller or their contacts. Measles most commonly affects children and is preventable with vaccination, given in Australia in two doses at 12 and 18 months old. But in light of current outbreaks globally, is there a case for reviewing the timing of measles vaccinations? Some Measles Basics Measles is caused by a virus belonging to the genus Morbillivirus. Symptoms include a fever, cough, runny nose and a rash. While it presents as a mild illness in most cases, measles can lead to severe disease requiring hospitalisation, and even death. Large outbreaks can overwhelm health systems. Measles can have serious health consequences, such as in the brain and the immune system, years after the infection. Measles spreads from person to person via small respiratory droplets that can remain suspended in the air for two hours. It's highly contagious – one person with measles can spread the infection to 12–18 people who aren't immune. Because measles is so infectious, the World Health Organization (WHO) recommends two-dose vaccination coverage above 95% to stop the spread and achieve ' herd immunity '. Low and declining vaccine coverage, especially since the COVID pandemic, is driving global outbreaks. When Are Children Vaccinated Against Measles? Newborn babies are generally protected against measles thanks to maternal antibodies. Maternal antibodies get passed from the mother to the baby via the placenta and in breast milk, and provide protection against infections including measles. The WHO advises everyone should receive two doses of measles vaccination. In places where there's a lot of measles circulating, children are generally recommended to have the first dose at around nine months old. This is because it's expected maternal antibodies would have declined significantly in most infants by that age, leaving them vulnerable to infection. If maternal measles antibodies are still present, the vaccine is less likely to produce an immune response. Research has also shown a measles vaccine given at less than 8.5 months of age can result in an antibody response which declines more quickly. This might be due to interference with maternal antibodies, but researchers are still trying to understand the reasons for this. A second dose of the vaccine is usually given 6–9 months later. A second dose is important because about 10–15% of children don't develop antibodies after the first vaccine. In settings where measles transmission is under better control, a first dose is recommended at 12 months of age. Vaccination at 12 months compared with nine months is considered to generate a stronger, longer-lasting immune response. In Australia, children are routinely given the measles-mumps- rubella (MMR) vaccine at 12 months and the measles-mumps-rubella-varicella (MMRV, with 'varicella' being chickenpox) vaccine at 18 months. Babies at higher risk of catching the disease can also be given an additional early dose. In Australia, this is recommended for infants as young as six months when there's an outbreak or if they're travelling overseas to a high-risk setting. A New Study Looking At Measles Antibodies In Babies A recent review looked at measles antibody data from babies under nine months old living in low- and middle-income countries. The review combined the results from 20 studies, including more than 8,000 babies. The researchers found that while 81% of newborns had maternal antibodies to measles, only 30% of babies aged four months had maternal antibodies. This study suggests maternal antibodies to measles decline much earlier than previously thought. It raises the question of whether the first dose of measles vaccine is given too late to maximise infants' protection, especially when there's a lot of measles around. Should We Bring The Measles Vaccine Forward In Australia? All of the data in this study comes from low- and middle-income countries, and might not reflect the situation in Australia where we have much higher vaccine coverage for measles, and very few cases. Australia's coverage for two doses of the MMR vaccine at age two is above 92%. Although this is lower than the optimal 95%, the overall risk of measles surging in Australia is relatively low. Nonetheless, there may be a case for broadening the age at which an early extra dose of the measles vaccine can be given to children at higher risk. In New Zealand, infants as young as four months can receive a measles vaccine before travelling to an endemic country. But the current routine immunisation schedule in Australia is unlikely to change. Adding an extra dose to the schedule would be costly and logistically difficult. Lowering the age for the first dose may have some advantages in certain settings, and doesn't pose any safety concerns, but further evidence would be required to support this change. In particular, research is needed to ensure it wouldn't negatively affect the longer-term protection that vaccination offers from measles. Making Sure You're Protected In the meantime, ensuring high levels of measles vaccine coverage with two doses is a global priority. People born after 1966 are recommended to have two doses of measles vaccine. This is because those born before the mid-1960s likely caught measles as children (when the vaccine was not yet available) and would therefore have natural immunity. If you're unsure about your vaccination status, you can check this through the Australian Immunisation Register. If you don't have a documented record, ask your doctor for advice. Catch-up vaccination is available under the National Immunisation Program. (Authors: Meru Sheel, Associate Professor, Infectious Diseases, Immunisation and Emergencies (IDIE) Group, Sydney School of Public Health, University of Sydney and Anita Heywood, Associate Professor, School of Population Health, UNSW Sydney) (Disclosure statement: Meru Sheel receives funding from the National Health and Medical Research Council and the Department of Foreign Affairs and Trade. Anita Heywood does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.)